Sun Pharma Advanced Research Company (SPARC) reported a net loss of Rs 56.72 crore in Q4 FY21, lower than net loss of Rs 99.54 crore in Q4 FY20.
Net sales jumped 23.6% to Rs 28.06 crore in Q4 FY21 from Rs 22.71 crore in Q4 FY20. Total expenses fell 32.11% to Rs 85.11 crore in Q4 FY21 over Q4 FY20.For FY 2021, the company reported net loss of Rs 151.14 crore in the tear ended March 2021, lower than net loss of Rs 312.40 crore in the tear ended March 2020. Net sales jumped 229.29% to Rs 252.96 crore in FY21 over FY20.
SPARC is engaged in research and experimental development on natural sciences and engineering. The company operates through pharmaceuticals research and development segment.
Shares of SPARC declined 2.14% to Rs 222.15 on BSE. The stock traded in the range of Rs 217.15 to Rs 231 so far.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
